SCHEMBL8770871

SCHEMBL8770871

Cc1ccc(C(=O)Nc2ccc(C(=O)c3ccc(NC(=O)c4ccc(C)cc4C)cc3)cc2)c(C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
KMT2A Q03164 3/20 0.63
KDM4E B2RXH2 2/20 0.63
MAPT P10636 2/20 0.63
GLA P06280 1/20 0.63
MCL1 Q07820 1/20 0.63
RAB9A P51151 4/20 0.59
NPC1 O15118 2/20 0.59
AVPR2 P30518 1/20 0.59
GPR27 Q9NS67 1/20 0.59
F2 P00734 2/20 0.57
F10 P00742 2/20 0.57
PLAU P00749 2/20 0.57
PLAT P00750 2/20 0.57
PLG P00747 2/20 0.57
TDP1 Q9NUW8 1/20 0.56
POLB P06746 1/20 0.53
MEN1 O00255 1/20 0.51
KLK1 P06870 1/20 0.51
KLK6 Q92876 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8235539 0.90 KMT2A (0.63) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL4147334 0.85 GPR27 (0.72) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL1687866 0.83 NR1H4 (0.67) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL19501647 0.83 AVPR2 (0.70) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL30192798 0.82 TYK2 (0.67) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL15177197 0.80 RAB9A (0.59) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL13219586 0.78 KMT2A (0.66) ALDH1A1KMT2AKDM4EMAPTRAB9A
SCHEMBL10952578 0.78 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTRAB9ANPC1
SCHEMBL13964389 0.78 F10 (0.55) ALDH1A1KMT2AKDM4EMAPTGLA
SCHEMBL21021070 0.77 HDAC1 (0.59) ALDH1A1KMT2AMAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9622991-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2017-04-18 US disclosed
US-9144557-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2015-09-29 US disclosed
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2015-09-10 US disclosed
US-20140243324-A1 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2014-08-28 US disclosed
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2012-11-22 US disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243324-A1 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS HGF, EPOR, MPL ALDH1A1 3228/4885KMT2A 2225/4885KDM4E 3484/4885
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF ALDH1A1 2736/4885KMT2A 806/4885KDM4E 1944/4885
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF ALDH1A1 2736/4885KMT2A 806/4885KDM4E 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.